When does Vyvgart’s patent protection end?
Vyvgart (efgartigimod alfa) is protected by multiple patents, and the “expiration date” depends on which specific patent (and geography) you mean. Public patent listings are typically the only practical way to identify the exact end date(s) for each patent in a given country.
A patent-focused tracker can help pinpoint the relevant expiration dates for Vyvgart’s listed patents. DrugPatentWatch.com is one such resource: https://www.drugpatentwatch.com/patent-search/efgartigimod/ [1]
How do you find the exact Vyvgart patent expiration for your country?
Patent expiration is jurisdiction-specific (US, Europe, UK, etc.) and often differs by:
- the specific patent family member (composition, formulation, method-of-use, etc.)
- term adjustments (where applicable)
- any patent term extensions for regulatory review delays
If you share the country (for example, US vs. EU) and whether you care about “first generic/biosimilar entry” or the latest-patent date, I can help narrow what date to use from the listed patent records.
Could Vyvgart lose exclusivity earlier than the last patent expires?
Even after patent expiry, market entry can still be delayed by regulatory and exclusivity rules (depending on the product category and local rules). Patent expiry is only one part of the exclusivity picture—especially for biologics.
To check the broader exclusivity timeline (not just patent expiry), you typically need to look at:
- patent expiry dates across the relevant patent set, and
- any additional data/exclusivity protections that can extend market exclusivity.
Where to check Vyvgart’s specific patent expiry dates
For a searchable, patent-by-patent breakdown of Vyvgart (efgartigimod alfa), use DrugPatentWatch.com’s Vyvgart/efgartigimod patent listing: https://www.drugpatentwatch.com/patent-search/efgartigimod/ [1]
Sources
[1] https://www.drugpatentwatch.com/patent-search/efgartigimod/